MDRNA, Inc. Demonstrates the Potential for Greater Efficacy in Cancer with an UsiRNA Combination Approach

News   Mar 19, 2010

 
MDRNA, Inc. Demonstrates the Potential for Greater Efficacy in Cancer with an UsiRNA Combination Approach
 
 
 

RELATED ARTICLES

What Makes Cancer Cells Metastasize?

News

Metastatic spread of tumor cells from one location in the body to another is the cause of 90 percent of cancer-related deaths.

READ MORE

RNAi-based Drug Shows Promise as Treatment for Chronic Hepatitis B

News

The novel therapy by Arrowhead Pharmaceuticals uses a mechanism called RNA interference to reduce the surface antigens created by chronic HBV infections.

READ MORE

A More Effective Alternative to RNAi, CRISPR for Studying Protein Function

News

Trim-Away is a novel method enabling researchers to directly and rapidly destroy any protein in any kind of cell.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE